$34.13-$0.00 (0.0%)
iShares Evolved U.S. Innovative Healthcare ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
AMEX · KOL · USD
Stock price, dividends
Quote as of Dec 14, 2020, 08:59 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
VanEck Vectors Coal ETF’s quoted price sits in the upper half of its reported 52-week range, 4.44% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
VanEck Vectors Coal ETF’s forward annual dividend is $3.24 per share, paid annual. The forward yield is 3.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The VanEck Vectors Coal ETF (KOL) is designed to closely mirror, before accounting for fees and expenses, the total return performance (both price appreciation and income generation) of the MVIS® Global Coal Index. To achieve this objective, the fund typically commits at least 80% of its overall assets to the component securities that constitute its benchmark index. The MVIS® Global Coal Index encompasses companies operating within the global coal sector that generate a minimum of 50% of their income from various coal-related operations. These activities include the extraction, mining, and processing (cokeries) of coal, its transportation, the manufacturing of coal mining equipment, and the storage and trade of coal. This fund is classified as non-diversified.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 04:04 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE ANALYST VIEW
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
KEEP COMPARING
$34.13-$0.00 (0.0%)
iShares Evolved U.S. Innovative Healthcare ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$33.58+$0.01 (+0.03%)
Invesco RAFI Strategic US Small Company ETF’s quoted price sits in the lower half of its reported 52-week range, 12.17% below the high.
$71.00-$0.05 (-0.07%)
Invesco S&P Financials Revenue ETF’s quoted price sits in the upper half of its reported 52-week range, 0.01% below the high.
$9.45+$0.07 (+0.75%)
Global X Telemedicine & Digital Health ETF’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
$27.51+$0.03 (+0.11%)
Aptus Fortified Value ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$28.64-$0.10 (-0.34%)
iShares Trust’s quoted price sits in the upper half of its reported 52-week range, 4.28% below the high.
$22.23-$0.16 (-0.71%)
Invesco BLDRS Developed Markets 100 ADR Index Fund’s quoted price sits in the lower half of its reported 52-week range, 0.25% below the high.
$42.92$0.00 (0.0%)
First Trust Mega Cap AlphaDEX Fund’s quoted price sits in the upper half of its reported 52-week range, 1.08% below the high.